Last update 01 Nov 2024
Noden Pharma DAC

Noden Pharma DAC

Startups
|
Holding Company|
2016|
Ireland
|
10-50
|
www.nodenpharma.com

Overview

Tags

Cardiovascular Diseases
Other Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
renin1
VGSCs(Voltage-gated sodium channels)1

Related

3
Drugs associated with Noden Pharma DAC
Cocaine Hydrochloride
Target
VGSCs
Mechanism
Voltage-gated sodium channels blockers
Active Org.
Omnivium Pharmaceuticals LLC [+1]
Originator Org.
Genus Lifesciences, Inc.Genus Lifesciences, Inc.
Active Indication
Anesthesia
Inactive Indication
Cocaine-Related Disorders
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date14 Dec 2017
Aliskiren Fumarate
Target
renin
Mechanism
renin inhibitors
Active Org.
Novartis Pharma AG [+3]
Originator Org.
Novartis Pharma AG
Active Indication
Essential Hypertension [+1]
Inactive Indication
Acute Coronary Syndrome [+20]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date05 Mar 2007
Aliskiren Hemifumarate/Hydrochlorothiazide
Target
NCC x renin
Mechanism
NCC inhibitors [+1]
Active Org.-
Originator Org.
Novartis Pharma AG
Active Indication-
Inactive Indication
Essential Hypertension [+1]
Drug Highest PhaseWithdrawn
First Approval Ctry. / Loc.
US
First Approval Date18 Jan 2008
1
Clinical Trials associated with Noden Pharma DAC
NCT01420068 / CompletedNot Applicable
A Multicenter, Double-blind 52 to 104 Week Off-therapy Extension Study to Evaluate the Long Term Growth and Development of Pediatric Hypertensive Patients 6 - 17 Years of Age Previously Treated With Aliskiren in Studies CSPP100A2365 and/or CSPP100A2365E1
100 Clinical Results associated with Noden Pharma DAC
Login to view more data
0 Patents (Medical) associated with Noden Pharma DAC
Login to view more data
100 Deals associated with Noden Pharma DAC
Login to view more data
100 Translational Medicine associated with Noden Pharma DAC
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 26 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Aliskiren Fumarate
 ( renin )		Hypertension
More
Approved
Cocaine Hydrochloride
 ( VGSCs )		Anesthesia
More
Approved
Aliskiren Hemifumarate/Hydrochlorothiazide
 ( NCC x renin )		Hypertension
More
Withdrawn
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free